| FYE | Name: | 6-fluoranyl-~{N}-[(1-oxidanylcyclohexyl)methyl]-4-oxidanylidene-chromene-2-carboxamide | Formula: | C17 H18 F N O4 | SMILES: | OC1(CCCCC1)CNC(=O)C2=CC(=O)c3cc(F)ccc3O2 | InChi: | InChI=1S/C17H18FNO4/c18-11-4-5-14-12(8-11)13(20)9-15(23-14)16(21)19-10-17(22)6-2-1-3-7-17/h4-5,8-9,22H,1-3,6-7,10H2,(H,19,21) | Definition date: | 2018-08-17 | Last modified: | 2019-03-29 | Release date: | 2019-04-03 | Identifier: | 6-fluoranyl-~{N}-[(1-oxidanylcyclohexyl)methyl]-4-oxidanylidene-chromene-2-carboxamide |
|
| FZV | Name: | tert-butyl [(2S)-1-{[(2R)-1-oxo-3-phenyl-1-{[2-(pyridin-3-yl)ethyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate | Formula: | C30 H37 N3 O3 S | SMILES: | CC(OC(=O)NC(CSC(C(=O)NCCc1cccnc1)Cc2ccccc2)Cc3ccccc3)(C)C | InChi: | InChI=1S/C30H37N3O3S/c1-30(2,3)36-29(35)33-26(19-23-11-6-4-7-12-23)22-37-27(20-24-13-8-5-9-14-24)28(34)32-18-16-25-15-10-17-31-21-25/h4-15,17,21,26-27H,16,18-20,22H2,1-3H3,(H,32,34)(H,33,35)/t26-,27+/m0/s1 | Definition date: | 2018-05-02 | Last modified: | 2019-03-29 | Release date: | 2019-04-03 | Identifier: | tert-butyl [(2S)-1-{[(2R)-1-oxo-3-phenyl-1-{[2-(pyridin-3-yl)ethyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate |
|
| G0D | Name: | tert-butyl [(2R)-1-{[(2R)-1-oxo-3-phenyl-1-{[(pyridin-3-yl)methyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate | Formula: | C29 H35 N3 O3 S | SMILES: | C(SC(Cc1ccccc1)C(=O)NCc2cnccc2)C(Cc3ccccc3)NC(=O)OC(C)(C)C | InChi: | InChI=1S/C29H35N3O3S/c1-29(2,3)35-28(34)32-25(17-22-11-6-4-7-12-22)21-36-26(18-23-13-8-5-9-14-23)27(33)31-20-24-15-10-16-30-19-24/h4-16,19,25-26H,17-18,20-21H2,1-3H3,(H,31,33)(H,32,34)/t25-,26-/m1/s1 | Definition date: | 2018-05-02 | Last modified: | 2019-03-29 | Release date: | 2019-04-03 | Identifier: | tert-butyl [(2R)-1-{[(2R)-1-oxo-3-phenyl-1-{[(pyridin-3-yl)methyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate |
|
| G0J | Name: | Nalpha-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropyl}-N-[(pyridin-3-yl)methyl]-D-phenylalaninamide | Formula: | C29 H36 N4 O3 | SMILES: | C(=O)(C(Cc1ccccc1)NCC(NC(=O)OC(C)(C)C)Cc2ccccc2)NCc3cccnc3 | InChi: | InChI=1S/C29H36N4O3/c1-29(2,3)36-28(35)33-25(17-22-11-6-4-7-12-22)21-31-26(18-23-13-8-5-9-14-23)27(34)32-20-24-15-10-16-30-19-24/h4-16,19,25-26,31H,17-18,20-21H2,1-3H3,(H,32,34)(H,33,35)/t25-,26+/m0/s1 | Definition date: | 2018-05-02 | Last modified: | 2019-03-29 | Release date: | 2019-04-03 | Identifier: | Nalpha-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropyl}-N-[(pyridin-3-yl)methyl]-D-phenylalaninamide |
|
| G0M | Name: | tert-butyl [(2S)-1-{[(2R)-1-oxo-3-phenyl-1-{[(pyridin-3-yl)methyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate | Formula: | C29 H35 N3 O3 S | SMILES: | C(SC(Cc1ccccc1)C(=O)NCc2cnccc2)C(Cc3ccccc3)NC(=O)OC(C)(C)C | InChi: | InChI=1S/C29H35N3O3S/c1-29(2,3)35-28(34)32-25(17-22-11-6-4-7-12-22)21-36-26(18-23-13-8-5-9-14-23)27(33)31-20-24-15-10-16-30-19-24/h4-16,19,25-26H,17-18,20-21H2,1-3H3,(H,31,33)(H,32,34)/t25-,26+/m0/s1 | Definition date: | 2018-05-02 | Last modified: | 2019-03-29 | Release date: | 2019-04-03 | Identifier: | tert-butyl [(2S)-1-{[(2R)-1-oxo-3-phenyl-1-{[(pyridin-3-yl)methyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate |
|
| G0V | Name: | tert-butyl [(2R)-1-{[(2R)-1-oxo-3-phenyl-1-{[2-(pyridin-3-yl)ethyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate | Formula: | C30 H37 N3 O3 S | SMILES: | CC(OC(NC(Cc1ccccc1)CSC(C(=O)NCCc2cccnc2)Cc3ccccc3)=O)(C)C | InChi: | InChI=1S/C30H37N3O3S/c1-30(2,3)36-29(35)33-26(19-23-11-6-4-7-12-23)22-37-27(20-24-13-8-5-9-14-24)28(34)32-18-16-25-15-10-17-31-21-25/h4-15,17,21,26-27H,16,18-20,22H2,1-3H3,(H,32,34)(H,33,35)/t26-,27-/m1/s1 | Definition date: | 2018-05-02 | Last modified: | 2019-03-29 | Release date: | 2019-04-03 | Identifier: | tert-butyl [(2R)-1-{[(2R)-1-oxo-3-phenyl-1-{[2-(pyridin-3-yl)ethyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate |
|
| G0Y | Name: | tert-butyl [(2R)-1-{[(2S)-1-oxo-3-phenyl-1-{[2-(pyridin-3-yl)ethyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate | Formula: | C30 H37 N3 O3 S | SMILES: | C(C(Cc1ccccc1)NC(OC(C)(C)C)=O)SC(C(=O)NCCc2cccnc2)Cc3ccccc3 | InChi: | InChI=1S/C30H37N3O3S/c1-30(2,3)36-29(35)33-26(19-23-11-6-4-7-12-23)22-37-27(20-24-13-8-5-9-14-24)28(34)32-18-16-25-15-10-17-31-21-25/h4-15,17,21,26-27H,16,18-20,22H2,1-3H3,(H,32,34)(H,33,35)/t26-,27+/m1/s1 | Definition date: | 2018-05-02 | Last modified: | 2019-03-29 | Release date: | 2019-04-03 | Identifier: | tert-butyl [(2R)-1-{[(2S)-1-oxo-3-phenyl-1-{[2-(pyridin-3-yl)ethyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate |
|
| G1D | Name: | Nalpha-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropyl}-N-[2-(pyridin-3-yl)ethyl]-D-phenylalaninamide | Formula: | C30 H38 N4 O3 | SMILES: | C(=O)(C(NCC(Cc1ccccc1)NC(=O)OC(C)(C)C)Cc2ccccc2)NCCc3cccnc3 | InChi: | InChI=1S/C30H38N4O3/c1-30(2,3)37-29(36)34-26(19-23-11-6-4-7-12-23)22-33-27(20-24-13-8-5-9-14-24)28(35)32-18-16-25-15-10-17-31-21-25/h4-15,17,21,26-27,33H,16,18-20,22H2,1-3H3,(H,32,35)(H,34,36)/t26-,27+/m0/s1 | Definition date: | 2018-05-02 | Last modified: | 2019-03-29 | Release date: | 2019-04-03 | Identifier: | Nalpha-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropyl}-N-[2-(pyridin-3-yl)ethyl]-D-phenylalaninamide |
|
| G1J | Name: | tert-butyl [(2R)-1-{[(2S)-1-oxo-3-phenyl-1-{[(pyridin-3-yl)methyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate | Formula: | C29 H35 N3 O3 S | SMILES: | C(Cc1ccccc1)(C(=O)NCc2cnccc2)SCC(Cc3ccccc3)NC(=O)OC(C)(C)C | InChi: | InChI=1S/C29H35N3O3S/c1-29(2,3)35-28(34)32-25(17-22-11-6-4-7-12-22)21-36-26(18-23-13-8-5-9-14-23)27(33)31-20-24-15-10-16-30-19-24/h4-16,19,25-26H,17-18,20-21H2,1-3H3,(H,31,33)(H,32,34)/t25-,26+/m1/s1 | Definition date: | 2018-05-02 | Last modified: | 2019-03-29 | Release date: | 2019-04-03 | Identifier: | tert-butyl [(2R)-1-{[(2S)-1-oxo-3-phenyl-1-{[(pyridin-3-yl)methyl]amino}propan-2-yl]sulfanyl}-3-phenylpropan-2-yl]carbamate |
|
| G9S | Name: | S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexadecanethioate | Formula: | C27 H53 N2 O8 P S | SMILES: | C(NC(CCNC(C(C(C)(COP(O)(=O)O)C)O)=O)=O)CSC(CCCCCCCCCCCCCCC)=O | InChi: | InChI=1S/C27H53N2O8PS/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-24(31)39-21-20-28-23(30)18-19-29-26(33)25(32)27(2,3)22-37-38(34,35)36/h25,32H,4-22H2,1-3H3,(H,28,30)(H,29,33)(H2,34,35,36)/t25-/m1/s1 | Definition date: | 2018-05-16 | Last modified: | 2019-03-29 | Release date: | 2019-04-03 | Identifier: | S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexadecanethioate |
|
| JU7 | Name: | 6-cyclohexylhexyl beta-D-glucopyranoside | Formula: | C18 H34 O6 | SMILES: | C1(C(C(C(OC1OCCCCCCC2CCCCC2)CO)O)O)O | InChi: | InChI=1S/C18H34O6/c19-12-14-15(20)16(21)17(22)18(24-14)23-11-7-2-1-4-8-13-9-5-3-6-10-13/h13-22H,1-12H2/t14-,15-,16+,17-,18-/m1/s1 | Definition date: | 2018-09-24 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | 6-cyclohexylhexyl beta-D-glucopyranoside |
|
| GXB | Name: | Sialylated precision glycomacromolecule | Formula: | C92 H139 N19 O39 | SMILES: | CC(=O)NCCN(CCNC(=O)CCC(=O)NCCOCCOCCNC(=O)CCC(=O)NCCOCCOCCNC(=O)CCC(=O)NCCOCCOCCNC(=O)CCC(=O)NCCN(CCNC(=O)CCC(N)=O)C(=O)c1ccc(Cn2cc(CO[C]3(C[CH](O)[CH](OC(C)=O)[CH](O3)[CH](O)[CH](O)CO)C(O)=O)nn2)cc1)C(=O)c4ccc(Cn5cc(COC6(CC(O)C(OC(C)=O)C(O6)C(O)C(O)CO)C(O)=O)nn5)cc4 | InChi: | InChI=1S/C92H139N19O39/c1-58(114)94-22-32-108(87(133)63-8-4-61(5-9-63)50-110-52-65(104-106-110)56-145-91(89(135)136)48-67(117)83(147-59(2)115)85(149-91)81(131)69(119)54-112)33-24-96-73(123)14-16-75(125)98-26-36-139-42-44-141-38-28-100-77(127)18-20-79(129)102-30-40-143-46-47-144-41-31-103-80(130)21-19-78(128)101-29-39-142-45-43-140-37-27-99-76(126)17-15-74(124)97-25-35-109(34-23-95-72(122)13-12-71(93)121)88(134)64-10-6-62(7-11-64)51-111-53-66(105-107-111)57-146-92(90(137)138)49-68(118)84(148-60(3)116)86(150-92)82(132)70(120)55-113/h4-11,52-53,67-70,81-86,112-113,117-120,131-132H,12-51,54-57H2,1-3H3,(H2,93,121)(H,94,114)(H,95,122)(H,96,123)(H,97,124)(H,98,125)(H,99,126)(H,100,127)(H,101,128)(H,102,129)(H,103,130)(H,135,136)(H,137,138)/t67?,68-,69?,70+,81?,82+,83?,84+,85?,86-,91?,92+/m0/s1 | Definition date: | 2018-10-15 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | 2-[[1-[[4-[2-acetamidoethyl-[2-[[4-[2-[2-[2-[[4-[2-[2-[2-[[4-[2-[2-[2-[[4-[2-[[4-[[4-[[(2~{R},4~{S},5~{R},6~{S})-5-acetyloxy-2-carboxy-4-oxidanyl-6-[(1~{R},2~{R})-1,2,3-tris(oxidanyl)propyl]oxan-2-yl]oxymethyl]-1,2,3-triazol-1-yl]methyl]phenyl]carbonyl-[2-[(4-azanyl-4-oxidanylidene-butanoyl)amino]ethyl]amino]ethylamino]-4-oxidanylidene-butanoyl]amino]ethoxy]ethoxy]ethylamino]-4-oxidanylidene-butanoyl]amino]ethoxy]ethoxy]ethylamino]-4-oxidanylidene-butanoyl]amino]ethoxy]ethoxy]ethylamino]-4-oxidanylidene-butanoyl]amino]ethyl]carbamoyl]phenyl]methyl]-1,2,3-triazol-4-yl]methoxy]-5-acetyloxy-4-oxidanyl-6-[1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylic acid |
|
| JVD | Name: | N-[(2R)-3-methylbutan-2-yl]-1H-benzotriazole-6-carboxamide | Formula: | C12 H16 N4 O | SMILES: | c1cc2c(cc1C(NC(C)C(C)C)=O)nnn2 | InChi: | InChI=1S/C12H16N4O/c1-7(2)8(3)13-12(17)9-4-5-10-11(6-9)15-16-14-10/h4-8H,1-3H3,(H,13,17)(H,14,15,16)/t8-/m1/s1 | Definition date: | 2018-10-02 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | N-[(2R)-3-methylbutan-2-yl]-1H-benzotriazole-6-carboxamide |
|
| Z3P | Name: | 3,3',3''-phosphoryltripropanoic acid | Formula: | C9 H15 O7 P | SMILES: | O=C(O)CCP(=O)(CCC(=O)O)CCC(=O)O | InChi: | InChI=1S/C9H15O7P/c10-7(11)1-4-17(16,5-2-8(12)13)6-3-9(14)15/h1-6H2,(H,10,11)(H,12,13)(H,14,15) | Definition date: | 2016-05-11 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | 3,3',3''-phosphoryltripropanoic acid |
|
| JGN | Name: | [(2~{S},4~{S})-1-[(5,7-dimethyl-1~{H}-indol-4-yl)methyl]-4-methoxy-piperidin-2-yl]methanol | Formula: | C18 H26 N2 O2 | SMILES: | CO[CH]1CCN(Cc2c(C)cc(C)c3[nH]ccc23)[CH](CO)C1 | InChi: | InChI=1S/C18H26N2O2/c1-12-8-13(2)18-16(4-6-19-18)17(12)10-20-7-5-15(22-3)9-14(20)11-21/h4,6,8,14-15,19,21H,5,7,9-11H2,1-3H3/t14-,15-/m0/s1 | Definition date: | 2019-02-25 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | [(2~{S},4~{S})-1-[(5,7-dimethyl-1~{H}-indol-4-yl)methyl]-4-methoxy-piperidin-2-yl]methanol |
|
| JGQ | Name: | 4-[(2~{S},4~{S})-4-ethoxy-1-[(5-methoxy-7-methyl-1~{H}-indol-4-yl)methyl]piperidin-2-yl]benzoic acid | Formula: | C25 H30 N2 O4 | SMILES: | CCO[CH]1CCN(Cc2c(OC)cc(C)c3[nH]ccc23)[CH](C1)c4ccc(cc4)C(O)=O | InChi: | InChI=1S/C25H30N2O4/c1-4-31-19-10-12-27(22(14-19)17-5-7-18(8-6-17)25(28)29)15-21-20-9-11-26-24(20)16(2)13-23(21)30-3/h5-9,11,13,19,22,26H,4,10,12,14-15H2,1-3H3,(H,28,29)/t19-,22-/m0/s1 | Definition date: | 2019-02-25 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | 4-[(2~{S},4~{S})-4-ethoxy-1-[(5-methoxy-7-methyl-1~{H}-indol-4-yl)methyl]piperidin-2-yl]benzoic acid |
|
| JGT | Name: | ~{N}-(2-bromanyl-4-methyl-naphthalen-1-yl)-4,5-dihydro-1~{H}-imidazol-2-amine | Formula: | C14 H14 Br N3 | SMILES: | Cc1cc(Br)c(NC2=NCCN2)c3ccccc13 | InChi: | InChI=1S/C14H14BrN3/c1-9-8-12(15)13(18-14-16-6-7-17-14)11-5-3-2-4-10(9)11/h2-5,8H,6-7H2,1H3,(H2,16,17,18) | Definition date: | 2019-02-25 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | ~{N}-(2-bromanyl-4-methyl-naphthalen-1-yl)-4,5-dihydro-1~{H}-imidazol-2-amine |
|
| GZ5 | Name: | (2~{R})-2-azanyl-~{N}-[6-[(6-chloranyl-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl]-3-(1~{H}-indol-3-yl)propanamide | Formula: | C30 H36 Cl N5 O | SMILES: | N[CH](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc3c4CCCCc4nc5cc(Cl)ccc35 | InChi: | InChI=1S/C30H36ClN5O/c31-21-13-14-24-28(18-21)36-27-12-6-4-10-23(27)29(24)33-15-7-1-2-8-16-34-30(37)25(32)17-20-19-35-26-11-5-3-9-22(20)26/h3,5,9,11,13-14,18-19,25,35H,1-2,4,6-8,10,12,15-17,32H2,(H,33,36)(H,34,37)/t25-/m1/s1 | Definition date: | 2018-10-26 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | (2~{R})-2-azanyl-~{N}-[6-[(6-chloranyl-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl]-3-(1~{H}-indol-3-yl)propanamide |
|
| GZY | Name: | 1-[(2S)-2-(3-methoxyphenyl)pyrrolidin-1-yl]ethan-1-one | Formula: | C13 H17 N O2 | SMILES: | C1C(N(C(=O)C)CC1)c2cccc(c2)OC | InChi: | InChI=1S/C13H17NO2/c1-10(15)14-8-4-7-13(14)11-5-3-6-12(9-11)16-2/h3,5-6,9,13H,4,7-8H2,1-2H3/t13-/m0/s1 | Definition date: | 2018-06-08 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | 1-[(2S)-2-(3-methoxyphenyl)pyrrolidin-1-yl]ethan-1-one |
|
| KCD | Name: | 7-(difluoromethoxy)-N-[trans-4-(2-hydroxypropan-2-yl)cyclohexyl]quinoline-3-carboxamide | Formula: | C20 H24 F2 N2 O3 | SMILES: | CC(C)(C1CCC(CC1)NC(c3cnc2cc(OC(F)F)ccc2c3)=O)O | InChi: | InChI=1S/C20H24F2N2O3/c1-20(2,26)14-4-6-15(7-5-14)24-18(25)13-9-12-3-8-16(27-19(21)22)10-17(12)23-11-13/h3,8-11,14-15,19,26H,4-7H2,1-2H3,(H,24,25)/t14-,15- | Definition date: | 2018-11-20 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | 7-(difluoromethoxy)-N-[trans-4-(2-hydroxypropan-2-yl)cyclohexyl]quinoline-3-carboxamide |
|
| H04 | Name: | 1-(2-ethoxyphenyl)piperazine | Formula: | C12 H18 N2 O | SMILES: | N1(CCNCC1)c2ccccc2OCC | InChi: | InChI=1S/C12H18N2O/c1-2-15-12-6-4-3-5-11(12)14-9-7-13-8-10-14/h3-6,13H,2,7-10H2,1H3 | Definition date: | 2018-06-08 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | 1-(2-ethoxyphenyl)piperazine |
|
| H0A | Name: | 1-[(2S)-2-(4-methoxyphenyl)-2,3,6,7-tetrahydro-1H-azepin-1-yl]ethan-1-one | Formula: | C15 H19 N O2 | SMILES: | c1(ccc(cc1)OC)C2N(CCC=CC2)C(=O)C | InChi: | InChI=1S/C15H19NO2/c1-12(17)16-11-5-3-4-6-15(16)13-7-9-14(18-2)10-8-13/h3-4,7-10,15H,5-6,11H2,1-2H3/t15-/m0/s1 | Definition date: | 2018-06-08 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | 1-[(2S)-2-(4-methoxyphenyl)-2,3,6,7-tetrahydro-1H-azepin-1-yl]ethan-1-one |
|
| H0D | Name: | N-(4-chlorophenyl)-N'-[(2R)-1-hydroxybutan-2-yl]urea | Formula: | C11 H15 Cl N2 O2 | SMILES: | N(C(CO)CC)C(=O)Nc1ccc(cc1)Cl | InChi: | InChI=1S/C11H15ClN2O2/c1-2-9(7-15)13-11(16)14-10-5-3-8(12)4-6-10/h3-6,9,15H,2,7H2,1H3,(H2,13,14,16)/t9-/m1/s1 | Definition date: | 2018-06-08 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | N-(4-chlorophenyl)-N'-[(2R)-1-hydroxybutan-2-yl]urea |
|
| H0G | Name: | 2-(3-methylphenyl)-N-(1,2-oxazol-3-yl)acetamide | Formula: | C12 H12 N2 O2 | SMILES: | N(C(Cc1cccc(C)c1)=O)c2ccon2 | InChi: | InChI=1S/C12H12N2O2/c1-9-3-2-4-10(7-9)8-12(15)13-11-5-6-16-14-11/h2-7H,8H2,1H3,(H,13,14,15) | Definition date: | 2018-06-08 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | 2-(3-methylphenyl)-N-(1,2-oxazol-3-yl)acetamide |
|
| H0J | Name: | 5-(pyridin-2-yl)thiophene-2-carbothioamide | Formula: | C10 H8 N2 S2 | SMILES: | n2c(c1sc(cc1)C(=S)N)cccc2 | InChi: | InChI=1S/C10H8N2S2/c11-10(13)9-5-4-8(14-9)7-3-1-2-6-12-7/h1-6H,(H2,11,13) | Definition date: | 2018-06-08 | Last modified: | 2019-03-22 | Release date: | 2019-03-27 | Identifier: | 5-(pyridin-2-yl)thiophene-2-carbothioamide |
|